Forums. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). Most bio's get. Expand. We are a team of expert financial advisers each specialising in different, yet complementary areas. . Invex Therapeutics Ltd. Created with Sketch. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Share I've got no issues with it. you post every single trade that is a sell onto Hotcopper. Created with Sketch. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. ASX - By Stock. IXC Valuation Report MST. ASX - Day TradingNotice of Webinar & Investor PresentationCreated with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. 38 Biotechnology stocks are valued based on a risk. 5% last year. is 19. Charts. Andrew Forrest , or his entities have been involved with IXC since inception. Join the HotCopper ASX share market forum today for free. , page-136. Cannot wait. At that time the total costs of IIH exceeded $444,000,000. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Only took that large seller to sell, now liquidity has dried up and. Created with Sketch. Created with Sketch. Trading HaltIXC Valuation Report MST. ASX - By Stock. When can we expect some update or. Created with Sketch. I think IXC has the potential to do better. IXC Valuation Report MST. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. Latest Posts. Orphan drug status. ASX - By Stock. Created with Sketch. International Markets. I guess that's why retail performs so poorly on average, so many think they are long term investors but can't hold onto their shares for more. . INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC IXC chart IXC invex therapeutics ltd IXC chart 1 Last ralom 17,015 Posts. ASX - By Stock. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. IXC Valuation Report MST. Very tempted to buy them back today at 19c. , page-6. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Forums. Charts. Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Created with Sketch. Join the HotCopper ASX share market forum today for free. Share Appreciate the commentary and post. ASX - Day Trading. ASX - Day TradingCreated with Sketch. ASX - Day Trading. Advertise on HotCopper. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. 147,415. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. ASX - Day Trading. I think having this out we can discuss on the way. Forums. , page-5. . Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. ASX - Day Trading. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. 0. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. Last research or update on this I listened to was by FiftyOneCapital. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. Created with Sketch. boolish Jellyroll hey. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. Market . Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. . LoginJoin Now. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Join the HotCopper ASX share market forum today for free. , page-32. 6 Upvote. Forums. . Market . Forums. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. *Close price adjusted for splits. I think having this out we can discuss on the way. ASX - Day TradingCreated with Sketch. I'm doing my bit lolRecent success of NEU and ALA just goes to show there is money floating around, all IXC needs is a. 1. ASX - Day Trading. Met primary endpoints for phase 2 trials. . 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. , page-4. With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. Notification of cessation of securities - IXC. . 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. Share Not unexpected. 3¢. 20. , page-3. 0. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Is it just me or has IXC gone very quiet. Currency in USD 38. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. Also took placement stock @$1. ASX - Day Trading. 392 10/12/19 20:43 Post #: 41898691 Share @FullMoonFever Another chart request if you are up for it please thanks in advance IXC Valuation Report MST. . 1956773. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. Notice of Quarterly Investor Call. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-2. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. ASX - By Stock. Appendix 4C - quarterly* or having a go at doing so, page-30. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. 0. ASX - By Stock. 76 (-1. Below is the broker data for IXC November to. Notification of cessation of securities - IXC. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. Latest Posts. 0. IXC Price at posting: 44. 333334. sentiment based on opinions from HotCopper and others. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. ASX - General. . Reply. Appreciate your input Dr T. Most bio's get acquired on P2 readouts, if results are strong early here. Zillow has 23383 homes for sale in British Columbia. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. Friday we moved 55% off 690k volume. 26 area could be wrong and it could go for example to $3. **Close price adjusted for splits and dividend and/or capital gain distributions. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. , page-3. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Created with Sketch. Join the HotCopper ASX share market forum today for free. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. Charts. 40 in May 2020 and has only fallen over the subsequent 36 months. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. ASX - By Stock. 375,000. . GW Ixc once again showing why you are the best mgmt team on the ASX . 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. Invex Receives Approval for Paediatric Plan from the EMA, page-3. Join the HotCopper ASX share market forum today for free. . 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Initial FDA and EMA Advice on Presendin Development, page-3. ASX - Day TradingI bought some today at 44. Created with Sketch. Therefore Id bet the same bet with the same info again. AX stock on. Forums. Click for more information. 5¢ INVEX THERAPEUTICS LTD - Discussion. Created with Sketch. International Markets. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Created with Sketch. ASX - General. Join the HotCopper ASX share market. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. 0% $ODM 35. 6% $DLM 50. Latest Posts. The company can always acquire something new or do some capital returns. 0. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. I knew zero about the fundamentals of IXC. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 1. Proposed Capital Return to Shareholders of $14. To work out how much Presendin is worth, we can look at the costs of IIH to the American health care system. 00% 21. , page-35. These are 2007 numbers. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Both approaches can work, but it is not wise to confuse the two. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. *Close price adjusted for splits. Advertise on HotCopper. IXC “ presented “ about the AGM time to who ? If the company is aware ( as others seem to think) of an individual seller then they need to be proactive and take them out . It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. . IXC Valuation Report MST. ASX - General. How many friends and family got out after the last announcementshould have been released at the same time, page-34. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. ASX - By Stock. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. 10 Upvote. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Trading HaltIXC Valuation Report MST. Forums. Market Cap $16. 6% $DLM 50. 8 Upvote Created with Sketch. Created with Sketch. , page-17. . Market . Latest Posts. Created with Sketch. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Charts. Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. ASX - By Stock. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. 333334. ASX - Day Trading. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. is there any news release, or SP increasing due to only the market showing interest, page-2. sentiment based on opinions from HotCopper and others. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. ASX - By Stock. Notice of Annual General Meeting/Proxy Form, page-2. Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. 0 Great analysis. Created with Sketch. Forums. Forums. . Read in the announcement, has changed name and he has bought more ixc, page-2. Created with Sketch. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. ASX - By Stock. A new thread to put trading comments / reasoning / opinions in. Market . Created with Sketch. Latest Posts. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. 375,000. ASX - Short Term Trading. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. , page-75. Forums. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. . Very impressive. $100-200k might be the minimum for the market to take notice. Charts. Created with Sketch. Spot on - filled the 1. A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. . ASX - Day Trading. ASX - Short Term Trading. Invex Receives Approval for Paediatric Plan from the EMA, page-3. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. ASX - By Stock. Theres alot of breakdowns above that are yet to be backtested. Charts. Target our investor community with our suite of Hotcopper Advertising opportunities. , page-20. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. IXC (ASX) Ann: Trading Halt - HotCopper. Created with Sketch. ASX - Short Term Trading. ASX - By Stock. It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease. Been. Last edited by ejjwj: 28/06/23. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Created with Sketch. Latest Posts. ASX - Short Term Trading. Latest Posts. ASX - By Stock. Created with Sketch. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Created with Sketch. Latest Posts. Cold Comfort Ice Cream Company, Victoria, British Columbia. , page-5. , page-196. . , page-4. Discover historical prices for IXC. Latest Posts. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Share IXC needs to be proactive and release a statement. . Discover historical prices for IXC. ASX - General. IXC Valuation Report MST. . Forums. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. . ASX - Short Term Trading. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. Strong buy side, sell side still very thin. 5 cents. So your thesis is right on a long time time frame. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. About 90 percent of the U. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. ASX - By Stock. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. ASX - Short Term Trading. IXC (ASX) Ann: Trading Halt - HotCopper. 76 (-1. Just a matter of time really. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. ASX - By Stock. Notice of Investor Call and Presentation, page-2. 3¢. Latest Posts. . Release Date: 20/03/23 08:11; Summary: German Approval for IIH EVOLVE Phase 3 Clinical Trial; Price Sensitive: Yes; Download Document 195. , page-2. 0 Great. Trading HaltDCF Valuation: IXC Intrinsic Value of $6. My understanding is that NEU went from around $1. Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. In 2005, IIH cost the American health care. ASX - Short Term Trading. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. Created with Sketch. Created with Sketch. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. AX stock on Yahoo Finance. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. ASX - Short Term Trading.